APA Zitierstil

Kortylewski, M., & Pal, S. K. (2014). The dark side of Toll-like receptor signaling: TLR9 activation limits the efficacy cancer radiotherapy. Landes Bioscience.

Chicago Zitierstil

Kortylewski, Marcin, und Sumanta K. Pal. The Dark Side of Toll-like Receptor Signaling: TLR9 Activation Limits the Efficacy Cancer Radiotherapy. Landes Bioscience, 2014.

MLA Zitierstil

Kortylewski, Marcin, und Sumanta K. Pal. The Dark Side of Toll-like Receptor Signaling: TLR9 Activation Limits the Efficacy Cancer Radiotherapy. Landes Bioscience, 2014.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.